Corvus Pharmaceuticals (CRVS) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

CRVS is expected to report earnings to rise 60.00% to -11 cents per share on October 31

Corvus Pharmaceuticals CRVS Stock Earnings Reports

Q3'24

Est.

$-0.11

Q2'24

Beat

by $0.05

Q1'24

Est.

$-0.12

Q4'23

Missed

by $0.02

Q3'23

Est.

$-0.12

The last earnings report on August 06 showed earnings per share of -7 cents, beating the estimate of -11 cents. With 513.51K shares outstanding, the current market capitalization sits at 344.03M.

View a ticker or compare two or three

Compare

CRVS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CRVS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for CRVS (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a provider of anticancer immuno-oncology drugs

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

863 Mitten Road

Phone

+1 650 900-4520

Employees

Web

https://www.corvuspharma.com